Old Web
English
Sign In
Acemap
>
authorDetail
>
Hidetoshi Ikeoka
Hidetoshi Ikeoka
Medicine
Neuraminidase
monetary value
Family medicine
Titer
4
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cost-effectiveness of Baloxavir Marboxil compared with Laninamivir for the treatment of influenza in patients at high risk for complications in Japan.
2021
Current Medical Research and Opinion
Mariia Dronova
Hidetoshi Ikeoka
Naoya Itsumura
Nobuo Hirotsu
Amir Ansaripour
Samuel Aballéa
Yoshie Onishi
Mark Hill
Ataru Igarashi
Show All
Source
Cite
Save
Citations (1)
Estimation of the cost of influenza antiviral medication guidance or support provided by healthcare professionals: A questionnaire survey in Japan.
2021
Journal of Medical Economics
Kenji Kurazono
Hidetoshi Ikeoka
Shinzo Hiroi
Kosuke Iwasaki
Tomomi Takeshima
Manabu Akazawa
Show All
Source
Cite
Save
Citations (0)
Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysis.
2021
Journal of Medical Economics
Naoki Hosogaya
Takahiro Takazono
Akira Yokomasu
Shinzo Hiroi
Hidetoshi Ikeoka
Kosuke Iwasaki
Tomomi Takeshima
Hiroshi Mukae
Show All
Source
Cite
Save
Citations (1)
A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients
2019
Current Medical Research and Opinion
Vanessa Taieb
Hidetoshi Ikeoka
Fang Fang Ma
Katarzyna Borkowska
S. Aballea
Keiko Tone
Nobuo Hirotsu
Show All
Source
Cite
Save
Citations (13)
1